Chemoinformaics analysis of 15-OXOOCTACOSANOIC ACID
| Molecular Weight | 438.737 | nRot | 26 |
| Heavy Atom Molecular Weight | 384.305 | nRig | 5 |
| Exact Molecular Weight | 438.407 | nRing | 0 |
| Solubility: LogS | -5.333 | nHRing | 0 |
| Solubility: LogP | 6.52 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 85.1728 |
| nHD | 1 | BPOL | 55.9092 |
| QED | 0.305 |
| Synth | 2.829 |
| Natural Product Likeliness | 1.213 |
| NR-PPAR-gamma | 0.985 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.006 |
| CACO-2 | -4.629 |
| MDCK | 0.00000351 |
| BBB | 0.285 |
| PPB | 0.951184 |
| VDSS | 0.735 |
| FU | 0.0265801 |
| CYP1A2-inh | 0.125 |
| CYP1A2-sub | 0.144 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.243 |
| CYP2c9-sub | 0.987 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.174 |
| CYP3a4-inh | 0.24 |
| CYP3a4-sub | 0.021 |
| CL | 5.924 |
| T12 | 0.646 |
| hERG | 0.001 |
| Ames | 0.059 |
| ROA | 0.002 |
| SkinSen | 0.976 |
| Carcinogencity | 0.094 |
| EI | 0.982 |
| Respiratory | 0.444 |
| NR-Aromatase | 0.055 |
| Antiviral | No |
| Prediction | 0.624548 |